ovalbumin and maltodextrin

ovalbumin has been researched along with maltodextrin* in 2 studies

Trials

1 trial(s) available for ovalbumin and maltodextrin

ArticleYear
Effect of different protein sources on satiation and short-term satiety when consumed as a starter.
    Nutrition journal, 2011, Dec-23, Volume: 10

    Because the source of protein may play a role in its satiating effect, we investigated the effect of different proteins on satiation and short-term satiety.. Two randomized single-blind cross-over studies were completed. In the first study, we investigated the effect of a preload containing 20 g of casein, whey, pea protein, egg albumin or maltodextrin vs. water control on food intake 30 min later in 32 male volunteers (25 ± 4 yrs, BMI 24 ± 0.4 kg/m(2)). Subjective appetite was assessed using visual analogue scales at 10 min intervals after the preload. Capillary blood glucose was measured every 30 min during 2 hrs before and after the ad libitum meal. In the second study, we compared the effect of 20 g of casein, pea protein or whey vs. water control on satiation in 32 male volunteers (25 ± 0.6 yrs, BMI 24 ± 0.5 kg/m(2)). The preload was consumed as a starter during an ad libitum meal and food intake was measured. The preloads in both studies were in the form of a beverage.. In the first study, food intake was significantly lower only after casein and pea protein compared to water control (P = 0.02; 0.04 respectively). Caloric compensation was 110, 103, 62, 56 and 51% after casein, pea protein, whey, albumin and maltodextrin, respectively. Feelings of satiety were significantly higher after casein and pea protein compared to other preloads (P < 0.05). Blood glucose response to the meal was significantly lower when whey protein was consumed as a preload compared to other groups (P < 0.001). In the second study, results showed no difference between preloads on ad libitum intake. Total intake was significantly higher after caloric preloads compared to water control (P < 0.05).. Casein and pea protein showed a stronger effect on food intake compared to whey when consumed as a preload. However, consuming the protein preload as a starter of a meal decreased its impact on food intake as opposed to consuming it 30 min before the meal.

    Topics: Adult; Appetite; Blood Glucose; Caseins; Cross-Over Studies; Dietary Proteins; Eating; Humans; Male; Milk Proteins; Ovalbumin; Pisum sativum; Plant Proteins; Polysaccharides; Satiation; Single-Blind Method; Time Factors; Whey Proteins

2011

Other Studies

1 other study(ies) available for ovalbumin and maltodextrin

ArticleYear
Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 06-28, Volume: 232

    The intranasal administration of proteins using nanoparticles is a promising approach for several applications, especially for mucosal vaccines. Delivery of protein within the epithelial barrier is a key point to elicit an immune response and nano-carrier has to show no toxicity. The aim of this work was to elucidate the interactions of cationic porous nanoparticles loaded with protein delivery for antigen delivery in the nose. We investigated the loading, the cellular delivery and the epithelial transcytosis of proteins associated to these nanoparticles containing an anionic lipid in their core (NPL). NPL were highly endocytosed by airway epithelial cells and significantly improved the protein delivery into the cell. In vitro transcytosis studies showed that NPL did not modify the in vitro epithelial permeability suggesting no toxicity of these carriers. Moreover protein and NPL did not translocate the epithelial barrier. In vivo studies demonstrated that NPL prolonged the nasal residence time of the protein and no NPL were found beyond the epithelial barrier in vivo, precluding a negative side effect. All together these results establish the NPL as a bio-eliminable and optimal vaccine carrier.

    Topics: Administration, Intranasal; Animals; Antigens; Drug Carriers; Endocytosis; Epichlorohydrin; Epoxy Compounds; Mice; Nanoparticles; Nasal Mucosa; Ovalbumin; Permeability; Polysaccharides; Quaternary Ammonium Compounds

2016